Universal Health Services - UHS Stock Forecast, Price & News

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Universal Health Services in the last twelve months. There are currently 5 sell ratings, 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" UHS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in UHS, but not buy additional shares or sell existing shares.
View UHS analyst ratings or view top-rated stocks.

13 analysts have issued 1-year price targets for Universal Health Services' shares. Their UHS share price forecasts range from $90.00 to $169.00. On average, they predict the company's stock price to reach $123.00 in the next year. This suggests a possible upside of 9.7% from the stock's current price.
View analysts price targets for UHS or view top-rated stocks among Wall Street analysts.

Universal Health Services' stock was trading at $129.66 at the beginning of 2022. Since then, UHS stock has decreased by 13.6% and is now trading at $112.09.
View the best growth stocks for 2022 here.

Universal Health Services saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 3,240,000 shares, an increase of 16.1% from the July 15th total of 2,790,000 shares. Based on an average trading volume of 827,500 shares, the short-interest ratio is presently 3.9 days. Currently, 5.1% of the company's stock are sold short.
View Universal Health Services' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, October 24th 2022.
View our UHS earnings forecast.

Universal Health Services, Inc. (NYSE:UHS) posted its quarterly earnings data on Monday, July, 25th. The health services provider reported $2.20 earnings per share for the quarter, beating the consensus estimate of $2.10 by $0.10. The health services provider earned $3.32 billion during the quarter, compared to the consensus estimate of $3.27 billion. Universal Health Services had a trailing twelve-month return on equity of 12.88% and a net margin of 5.94%. The company's revenue for the quarter was up 3.9% on a year-over-year basis. During the same period in the prior year, the business earned $3.76 EPS.
Read the conference call transcript.

Universal Health Services declared a quarterly dividend on Wednesday, July 20th. Stockholders of record on Thursday, September 1st will be paid a dividend of $0.20 per share on Thursday, September 15th. This represents a $0.80 annualized dividend and a dividend yield of 0.71%. The ex-dividend date of this dividend is Wednesday, August 31st.
Read our dividend analysis for UHS.

Universal Health Services (NYSE:UHS) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.71%. The dividend payout ratio is 8.15%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, UHS will have a dividend payout ratio of 6.72% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for UHS.

Universal Health Services announced that its board has initiated a stock repurchase plan on Thursday, February 24th 2022, which authorizes the company to repurchase $1,400,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 12.1% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's management believes its shares are undervalued.

Universal Health Services updated its FY 2022 earnings guidance on Thursday, July, 28th. The company provided EPS guidance of $9.60-$10.40 for the period, compared to the consensus EPS estimate of $11.69. The company issued revenue guidance of $13.23 billion-$13.37 billion, compared to the consensus revenue estimate of $13.49 billion.

237 employees have rated Universal Health Services Chief Executive Officer Alan B. Miller on Glassdoor.com. Alan B. Miller has an approval rating of 63% among the company's employees. This puts Alan B. Miller in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Universal Health Services investors own include UnitedHealth Group (UNH), Netflix (NFLX), Broadcom (AVGO), Alibaba Group (BABA), Bank of America (BAC), Walt Disney (DIS), Intel (INTC), Johnson & Johnson (JNJ), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

Universal Health Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "UHS."

Universal Health Services' stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (7.65%), Nuance Investments LLC (2.15%), Allspring Global Investments Holdings LLC (2.13%), JPMorgan Chase & Co. (1.64%), National Bank of Canada FI (0.68%) and Bank of Nova Scotia (0.49%). Insiders that own company stock include Eileen C Mcdonnell, Eileen C Mcdonnell, Elliot J Md Mba Sussman, Lawrence S Gibbs, Marc D Miller, Marc W Booth, Matthew Jay Peterson and Steve Filton.
View institutional ownership trends.

Shares of UHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of UHS stock can currently be purchased for approximately $112.09.

Universal Health Services (NYSE:UHS) has a market capitalization of $8.18 billion and generates $12.64 billion in revenue each year. The health services provider earns $991.59 million in net income (profit) each year or $9.82 on an earnings per share basis.

The company employs 89,400 workers across the globe.

Universal Health Services' mailing address is 367 S GULPH RD, KING OF PRUSSIA PA, 19406. The official website for the company is www.uhsinc.com. The health services provider can be reached via phone at (610) 768-3300, via email at karen.sterner@uhsinc.com, or via fax at 610-768-3336.